XML 74 R63.htm IDEA: XBRL DOCUMENT
v3.23.3

Derivatives - Unrealized Gains/(Losses) (Parenthetical) (Details) - USD ($) $ in Millions | 3 Months Ended | 9 Months Ended
--- | --- | ---
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022
Foreign Exchange Contract [Member] |  |  |  |
Derivative [Line Items] |  |  |  |
Gains/(losses) excluded from effectiveness testing recognized in other comprehensive income | $ (0.8) | $ 0.2 | $ 1.1 | $ (4.7)

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480237/815-40-50-5 + Details
Name: | us-gaap_DerivativeLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Gain/(Loss) excluded from effectiveness testing recognized in other comprehensive income based on an amortization approach + References No definition available. + Details
Name: | wu_GainLossExcludedFromEffectivenessTestingRecognizedInOtherComprehensiveIncomeBasedOnAmortizationApproach
Namespace Prefix: | wu_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_DerivativeInstrumentRiskAxis=us-gaap_ForeignExchangeContractMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |